nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP2B6—Thiotepa—sarcoma	0.271	0.485	CbGbCtD
Raloxifene—CYP3A4—Thiotepa—sarcoma	0.0832	0.149	CbGbCtD
Raloxifene—CYP2C8—Etoposide—sarcoma	0.0556	0.0997	CbGbCtD
Raloxifene—CYP2B6—Doxorubicin—sarcoma	0.0501	0.0897	CbGbCtD
Raloxifene—CYP3A4—Mitoxantrone—sarcoma	0.0358	0.0641	CbGbCtD
Raloxifene—CYP3A4—Vincristine—sarcoma	0.0246	0.0441	CbGbCtD
Raloxifene—CYP3A4—Etoposide—sarcoma	0.0226	0.0404	CbGbCtD
Raloxifene—CYP3A4—Doxorubicin—sarcoma	0.0154	0.0276	CbGbCtD
Raloxifene—ESR1—periosteum—sarcoma	0.00823	0.083	CbGeAlD
Raloxifene—EBP—uterus—sarcoma	0.00472	0.0476	CbGeAlD
Raloxifene—ESR2—mammary gland—sarcoma	0.00357	0.036	CbGeAlD
Raloxifene—EBP—liver—sarcoma	0.00324	0.0326	CbGeAlD
Raloxifene—SIGMAR1—mammary gland—sarcoma	0.00277	0.0279	CbGeAlD
Raloxifene—ESR1—mammary gland—sarcoma	0.00245	0.0247	CbGeAlD
Raloxifene—AOX1—myometrium—sarcoma	0.00244	0.0246	CbGeAlD
Raloxifene—AOX1—seminal vesicle—sarcoma	0.0022	0.0222	CbGeAlD
Raloxifene—ESR2—hematopoietic system—sarcoma	0.00218	0.0219	CbGeAlD
Raloxifene—ESR2—connective tissue—sarcoma	0.0021	0.0211	CbGeAlD
Raloxifene—CYP2C8—mammary gland—sarcoma	0.00202	0.0203	CbGeAlD
Raloxifene—SIGMAR1—myometrium—sarcoma	0.00196	0.0198	CbGeAlD
Raloxifene—HTR2B—myometrium—sarcoma	0.00196	0.0198	CbGeAlD
Raloxifene—ESR2—smooth muscle tissue—sarcoma	0.00192	0.0193	CbGeAlD
Raloxifene—SIGMAR1—seminal vesicle—sarcoma	0.00177	0.0179	CbGeAlD
Raloxifene—ESR1—myometrium—sarcoma	0.00174	0.0175	CbGeAlD
Raloxifene—CYP19A1—hematopoietic system—sarcoma	0.00171	0.0173	CbGeAlD
Raloxifene—ESR1—embryo—sarcoma	0.00167	0.0168	CbGeAlD
Raloxifene—CYP19A1—connective tissue—sarcoma	0.00165	0.0166	CbGeAlD
Raloxifene—ESR2—uterus—sarcoma	0.00164	0.0166	CbGeAlD
Raloxifene—AOX1—cardiac atrium—sarcoma	0.00159	0.016	CbGeAlD
Raloxifene—AOX1—uterus—sarcoma	0.00158	0.016	CbGeAlD
Raloxifene—ESR2—lymphoid tissue—sarcoma	0.00153	0.0154	CbGeAlD
Raloxifene—ESR1—hematopoietic system—sarcoma	0.00149	0.015	CbGeAlD
Raloxifene—SIGMAR1—smooth muscle tissue—sarcoma	0.00148	0.015	CbGeAlD
Raloxifene—HTR2B—smooth muscle tissue—sarcoma	0.00148	0.0149	CbGeAlD
Raloxifene—HTR2B—skin of body—sarcoma	0.00146	0.0147	CbGeAlD
Raloxifene—ESR1—connective tissue—sarcoma	0.00143	0.0145	CbGeAlD
Raloxifene—AOX1—tendon—sarcoma	0.00139	0.014	CbGeAlD
Raloxifene—ESR1—smooth muscle tissue—sarcoma	0.00131	0.0132	CbGeAlD
Raloxifene—CYP19A1—uterus—sarcoma	0.0013	0.0131	CbGeAlD
Raloxifene—SIGMAR1—cardiac atrium—sarcoma	0.00128	0.0129	CbGeAlD
Raloxifene—SIGMAR1—uterus—sarcoma	0.00127	0.0128	CbGeAlD
Raloxifene—HTR2B—uterus—sarcoma	0.00127	0.0128	CbGeAlD
Raloxifene—CYP2C8—hematopoietic system—sarcoma	0.00123	0.0124	CbGeAlD
Raloxifene—ESR2—testis—sarcoma	0.00119	0.012	CbGeAlD
Raloxifene—AOX1—testis—sarcoma	0.00115	0.0116	CbGeAlD
Raloxifene—ESR2—liver—sarcoma	0.00113	0.0114	CbGeAlD
Raloxifene—ESR1—uterus—sarcoma	0.00113	0.0114	CbGeAlD
Raloxifene—SIGMAR1—tendon—sarcoma	0.00112	0.0113	CbGeAlD
Raloxifene—HTR2B—tendon—sarcoma	0.00111	0.0112	CbGeAlD
Raloxifene—CYP2B6—hematopoietic system—sarcoma	0.0011	0.0111	CbGeAlD
Raloxifene—AOX1—liver—sarcoma	0.00109	0.0109	CbGeAlD
Raloxifene—SIGMAR1—bone marrow—sarcoma	0.00108	0.0109	CbGeAlD
Raloxifene—ESR1—lymphoid tissue—sarcoma	0.00105	0.0106	CbGeAlD
Raloxifene—Flushing—Dactinomycin—sarcoma	0.00104	0.00496	CcSEcCtD
Raloxifene—Breast pain—Epirubicin—sarcoma	0.00104	0.00495	CcSEcCtD
Raloxifene—Vasodilation—Epirubicin—sarcoma	0.00103	0.00491	CcSEcCtD
Raloxifene—Vasodilation procedure—Epirubicin—sarcoma	0.00103	0.00491	CcSEcCtD
Raloxifene—Angiopathy—Thiotepa—sarcoma	0.00103	0.00489	CcSEcCtD
Raloxifene—Sinusitis—Mitoxantrone—sarcoma	0.00102	0.00486	CcSEcCtD
Raloxifene—Hypoaesthesia—Vincristine—sarcoma	0.000997	0.00475	CcSEcCtD
Raloxifene—Cough increased—Epirubicin—sarcoma	0.00099	0.00472	CcSEcCtD
Raloxifene—Urinary tract disorder—Vincristine—sarcoma	0.00099	0.00472	CcSEcCtD
Raloxifene—Connective tissue disorder—Vincristine—sarcoma	0.000985	0.00469	CcSEcCtD
Raloxifene—Urethral disorder—Vincristine—sarcoma	0.000983	0.00468	CcSEcCtD
Raloxifene—Neoplasm malignant—Doxorubicin—sarcoma	0.000982	0.00468	CcSEcCtD
Raloxifene—Rhinitis—Mitoxantrone—sarcoma	0.000979	0.00466	CcSEcCtD
Raloxifene—Pharyngitis—Mitoxantrone—sarcoma	0.000969	0.00462	CcSEcCtD
Raloxifene—Breast pain—Doxorubicin—sarcoma	0.000961	0.00458	CcSEcCtD
Raloxifene—CYP2B6—skin of body—sarcoma	0.000957	0.00965	CbGeAlD
Raloxifene—Vasodilation—Doxorubicin—sarcoma	0.000955	0.00455	CcSEcCtD
Raloxifene—Vasodilation procedure—Doxorubicin—sarcoma	0.000955	0.00455	CcSEcCtD
Raloxifene—CYP19A1—testis—sarcoma	0.00094	0.00948	CbGeAlD
Raloxifene—Cardiac disorder—Vincristine—sarcoma	0.00093	0.00443	CcSEcCtD
Raloxifene—SIGMAR1—testis—sarcoma	0.000924	0.00932	CbGeAlD
Raloxifene—Cough increased—Doxorubicin—sarcoma	0.000916	0.00436	CcSEcCtD
Raloxifene—Pneumonia—Etoposide—sarcoma	0.00091	0.00433	CcSEcCtD
Raloxifene—Angiopathy—Vincristine—sarcoma	0.000909	0.00433	CcSEcCtD
Raloxifene—Pulmonary embolism—Epirubicin—sarcoma	0.000906	0.00432	CcSEcCtD
Raloxifene—Vaginal inflammation—Epirubicin—sarcoma	0.000906	0.00432	CcSEcCtD
Raloxifene—CYP19A1—liver—sarcoma	0.000888	0.00896	CbGeAlD
Raloxifene—Cystitis noninfective—Epirubicin—sarcoma	0.000885	0.00422	CcSEcCtD
Raloxifene—Cystitis—Epirubicin—sarcoma	0.000875	0.00417	CcSEcCtD
Raloxifene—SIGMAR1—liver—sarcoma	0.000873	0.00881	CbGeAlD
Raloxifene—ESR2—lymph node—sarcoma	0.000864	0.00872	CbGeAlD
Raloxifene—Cough—Thiotepa—sarcoma	0.000859	0.00409	CcSEcCtD
Raloxifene—Vaginal infection—Epirubicin—sarcoma	0.000856	0.00408	CcSEcCtD
Raloxifene—Vaginal inflammation—Doxorubicin—sarcoma	0.000839	0.004	CcSEcCtD
Raloxifene—Pulmonary embolism—Doxorubicin—sarcoma	0.000839	0.004	CcSEcCtD
Raloxifene—Arthralgia—Thiotepa—sarcoma	0.000838	0.00399	CcSEcCtD
Raloxifene—Myalgia—Thiotepa—sarcoma	0.000838	0.00399	CcSEcCtD
Raloxifene—Cramps of lower extremities—Epirubicin—sarcoma	0.000833	0.00397	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000832	0.00396	CcSEcCtD
Raloxifene—AOX1—lymph node—sarcoma	0.000832	0.00839	CbGeAlD
Raloxifene—CYP3A4—hematopoietic system—sarcoma	0.000832	0.00838	CbGeAlD
Raloxifene—Myalgia—Dactinomycin—sarcoma	0.000832	0.00396	CcSEcCtD
Raloxifene—Bladder pain—Epirubicin—sarcoma	0.00082	0.0039	CcSEcCtD
Raloxifene—Cystitis noninfective—Doxorubicin—sarcoma	0.000819	0.0039	CcSEcCtD
Raloxifene—ESR1—testis—sarcoma	0.000817	0.00823	CbGeAlD
Raloxifene—Cystitis—Doxorubicin—sarcoma	0.00081	0.00386	CcSEcCtD
Raloxifene—Hypoaesthesia—Etoposide—sarcoma	0.000808	0.00385	CcSEcCtD
Raloxifene—Urinary tract disorder—Etoposide—sarcoma	0.000802	0.00382	CcSEcCtD
Raloxifene—Infection—Thiotepa—sarcoma	0.000798	0.0038	CcSEcCtD
Raloxifene—Urethral disorder—Etoposide—sarcoma	0.000796	0.00379	CcSEcCtD
Raloxifene—Infection—Dactinomycin—sarcoma	0.000792	0.00377	CcSEcCtD
Raloxifene—Vaginal infection—Doxorubicin—sarcoma	0.000792	0.00377	CcSEcCtD
Raloxifene—Nervous system disorder—Thiotepa—sarcoma	0.000788	0.00375	CcSEcCtD
Raloxifene—Thrombocytopenia—Thiotepa—sarcoma	0.000786	0.00375	CcSEcCtD
Raloxifene—Vertigo—Vincristine—sarcoma	0.000784	0.00374	CcSEcCtD
Raloxifene—Thrombocytopenia—Dactinomycin—sarcoma	0.00078	0.00372	CcSEcCtD
Raloxifene—Skin disorder—Thiotepa—sarcoma	0.00078	0.00372	CcSEcCtD
Raloxifene—CYP2B6—lymphoid tissue—sarcoma	0.000775	0.00782	CbGeAlD
Raloxifene—ESR1—liver—sarcoma	0.000772	0.00779	CbGeAlD
Raloxifene—Cramps of lower extremities—Doxorubicin—sarcoma	0.00077	0.00367	CcSEcCtD
Raloxifene—Bladder pain—Doxorubicin—sarcoma	0.000758	0.00361	CcSEcCtD
Raloxifene—Diabetes mellitus—Epirubicin—sarcoma	0.000756	0.0036	CcSEcCtD
Raloxifene—Cardiac disorder—Etoposide—sarcoma	0.000754	0.00359	CcSEcCtD
Raloxifene—Flushing—Etoposide—sarcoma	0.000754	0.00359	CcSEcCtD
Raloxifene—Myalgia—Vincristine—sarcoma	0.000743	0.00354	CcSEcCtD
Raloxifene—Cough—Mitoxantrone—sarcoma	0.000742	0.00353	CcSEcCtD
Raloxifene—Angiopathy—Etoposide—sarcoma	0.000737	0.00351	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000732	0.00349	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000726	0.00346	CcSEcCtD
Raloxifene—Chest pain—Mitoxantrone—sarcoma	0.000724	0.00345	CcSEcCtD
Raloxifene—Myalgia—Mitoxantrone—sarcoma	0.000724	0.00345	CcSEcCtD
Raloxifene—Arthralgia—Mitoxantrone—sarcoma	0.000724	0.00345	CcSEcCtD
Raloxifene—Infection—Vincristine—sarcoma	0.000708	0.00337	CcSEcCtD
Raloxifene—Dyspepsia—Thiotepa—sarcoma	0.000707	0.00337	CcSEcCtD
Raloxifene—Hot flush—Epirubicin—sarcoma	0.000703	0.00335	CcSEcCtD
Raloxifene—Diabetes mellitus—Doxorubicin—sarcoma	0.0007	0.00333	CcSEcCtD
Raloxifene—Nervous system disorder—Vincristine—sarcoma	0.000698	0.00333	CcSEcCtD
Raloxifene—Menopausal symptoms—Epirubicin—sarcoma	0.000697	0.00332	CcSEcCtD
Raloxifene—Thrombocytopenia—Vincristine—sarcoma	0.000697	0.00332	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Thiotepa—sarcoma	0.000693	0.0033	CcSEcCtD
Raloxifene—Infection—Mitoxantrone—sarcoma	0.000689	0.00328	CcSEcCtD
Raloxifene—Hyperhidrosis—Vincristine—sarcoma	0.000688	0.00328	CcSEcCtD
Raloxifene—Pain—Thiotepa—sarcoma	0.000687	0.00327	CcSEcCtD
Raloxifene—Shock—Mitoxantrone—sarcoma	0.000682	0.00325	CcSEcCtD
Raloxifene—Pain—Dactinomycin—sarcoma	0.000682	0.00325	CcSEcCtD
Raloxifene—CYP19A1—lymph node—sarcoma	0.000681	0.00687	CbGeAlD
Raloxifene—Muscle spasms—Etoposide—sarcoma	0.00068	0.00324	CcSEcCtD
Raloxifene—Thrombocytopenia—Mitoxantrone—sarcoma	0.000679	0.00324	CcSEcCtD
Raloxifene—Skin disorder—Mitoxantrone—sarcoma	0.000674	0.00321	CcSEcCtD
Raloxifene—CYP2C8—testis—sarcoma	0.000673	0.00678	CbGeAlD
Raloxifene—Cerebrovascular accident—Epirubicin—sarcoma	0.000671	0.0032	CcSEcCtD
Raloxifene—Hyperhidrosis—Mitoxantrone—sarcoma	0.000671	0.00319	CcSEcCtD
Raloxifene—SIGMAR1—lymph node—sarcoma	0.00067	0.00675	CbGeAlD
Raloxifene—HTR2B—lymph node—sarcoma	0.000668	0.00674	CbGeAlD
Raloxifene—Gastrointestinal pain—Thiotepa—sarcoma	0.000657	0.00313	CcSEcCtD
Raloxifene—Gastrointestinal pain—Dactinomycin—sarcoma	0.000652	0.00311	CcSEcCtD
Raloxifene—Hot flush—Doxorubicin—sarcoma	0.000651	0.0031	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Vincristine—sarcoma	0.000649	0.00309	CcSEcCtD
Raloxifene—Migraine—Epirubicin—sarcoma	0.000648	0.00309	CcSEcCtD
Raloxifene—Menopausal symptoms—Doxorubicin—sarcoma	0.000645	0.00307	CcSEcCtD
Raloxifene—Insomnia—Vincristine—sarcoma	0.000644	0.00307	CcSEcCtD
Raloxifene—CYP2C8—liver—sarcoma	0.000636	0.00641	CbGeAlD
Raloxifene—Vertigo—Etoposide—sarcoma	0.000635	0.00303	CcSEcCtD
Raloxifene—Abdominal pain—Thiotepa—sarcoma	0.000635	0.00302	CcSEcCtD
Raloxifene—Body temperature increased—Thiotepa—sarcoma	0.000635	0.00302	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000632	0.00301	CcSEcCtD
Raloxifene—Abdominal pain—Dactinomycin—sarcoma	0.00063	0.003	CcSEcCtD
Raloxifene—Body temperature increased—Dactinomycin—sarcoma	0.00063	0.003	CcSEcCtD
Raloxifene—Loss of consciousness—Etoposide—sarcoma	0.000621	0.00296	CcSEcCtD
Raloxifene—Cerebrovascular accident—Doxorubicin—sarcoma	0.000621	0.00296	CcSEcCtD
Raloxifene—Cough—Etoposide—sarcoma	0.000617	0.00294	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Vincristine—sarcoma	0.000615	0.00293	CcSEcCtD
Raloxifene—Dyspepsia—Mitoxantrone—sarcoma	0.000611	0.00291	CcSEcCtD
Raloxifene—Pain—Vincristine—sarcoma	0.000609	0.0029	CcSEcCtD
Raloxifene—CYP2B6—testis—sarcoma	0.000603	0.00608	CbGeAlD
Raloxifene—Chest pain—Etoposide—sarcoma	0.000602	0.00287	CcSEcCtD
Raloxifene—Migraine—Doxorubicin—sarcoma	0.000599	0.00286	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000598	0.00285	CcSEcCtD
Raloxifene—Breast disorder—Epirubicin—sarcoma	0.000595	0.00283	CcSEcCtD
Raloxifene—Pain—Mitoxantrone—sarcoma	0.000593	0.00283	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000593	0.00282	CcSEcCtD
Raloxifene—ESR1—lymph node—sarcoma	0.000592	0.00597	CbGeAlD
Raloxifene—Gastrointestinal pain—Vincristine—sarcoma	0.000582	0.00277	CcSEcCtD
Raloxifene—Infection—Etoposide—sarcoma	0.000573	0.00273	CcSEcCtD
Raloxifene—CYP2B6—liver—sarcoma	0.000571	0.00575	CbGeAlD
Raloxifene—Influenza—Epirubicin—sarcoma	0.000569	0.00271	CcSEcCtD
Raloxifene—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000567	0.0027	CcSEcCtD
Raloxifene—Thrombocytopenia—Etoposide—sarcoma	0.000565	0.00269	CcSEcCtD
Raloxifene—Abdominal pain—Vincristine—sarcoma	0.000563	0.00268	CcSEcCtD
Raloxifene—Body temperature increased—Vincristine—sarcoma	0.000563	0.00268	CcSEcCtD
Raloxifene—Skin disorder—Etoposide—sarcoma	0.00056	0.00267	CcSEcCtD
Raloxifene—Hyperhidrosis—Etoposide—sarcoma	0.000558	0.00266	CcSEcCtD
Raloxifene—Breast disorder—Doxorubicin—sarcoma	0.00055	0.00262	CcSEcCtD
Raloxifene—Diarrhoea—Thiotepa—sarcoma	0.00055	0.00262	CcSEcCtD
Raloxifene—Abdominal pain—Mitoxantrone—sarcoma	0.000548	0.00261	CcSEcCtD
Raloxifene—Body temperature increased—Mitoxantrone—sarcoma	0.000548	0.00261	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000548	0.00261	CcSEcCtD
Raloxifene—Bronchitis—Epirubicin—sarcoma	0.000547	0.00261	CcSEcCtD
Raloxifene—Diarrhoea—Dactinomycin—sarcoma	0.000545	0.0026	CcSEcCtD
Raloxifene—Dizziness—Thiotepa—sarcoma	0.000531	0.00253	CcSEcCtD
Raloxifene—Influenza—Doxorubicin—sarcoma	0.000526	0.00251	CcSEcCtD
Raloxifene—Weight increased—Epirubicin—sarcoma	0.000518	0.00247	CcSEcCtD
Raloxifene—Vomiting—Thiotepa—sarcoma	0.000511	0.00243	CcSEcCtD
Raloxifene—Pneumonia—Epirubicin—sarcoma	0.00051	0.00243	CcSEcCtD
Raloxifene—Vomiting—Dactinomycin—sarcoma	0.000507	0.00241	CcSEcCtD
Raloxifene—Rash—Thiotepa—sarcoma	0.000506	0.00241	CcSEcCtD
Raloxifene—Bronchitis—Doxorubicin—sarcoma	0.000506	0.00241	CcSEcCtD
Raloxifene—Dermatitis—Thiotepa—sarcoma	0.000506	0.00241	CcSEcCtD
Raloxifene—Headache—Thiotepa—sarcoma	0.000503	0.0024	CcSEcCtD
Raloxifene—Rash—Dactinomycin—sarcoma	0.000503	0.00239	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Etoposide—sarcoma	0.000498	0.00237	CcSEcCtD
Raloxifene—Pain—Etoposide—sarcoma	0.000493	0.00235	CcSEcCtD
Raloxifene—Urinary tract infection—Epirubicin—sarcoma	0.000493	0.00235	CcSEcCtD
Raloxifene—Conjunctivitis—Epirubicin—sarcoma	0.000493	0.00235	CcSEcCtD
Raloxifene—Diarrhoea—Vincristine—sarcoma	0.000487	0.00232	CcSEcCtD
Raloxifene—Sweating—Epirubicin—sarcoma	0.000486	0.00232	CcSEcCtD
Raloxifene—Weight increased—Doxorubicin—sarcoma	0.000479	0.00228	CcSEcCtD
Raloxifene—Nausea—Thiotepa—sarcoma	0.000477	0.00227	CcSEcCtD
Raloxifene—Sinusitis—Epirubicin—sarcoma	0.000476	0.00227	CcSEcCtD
Raloxifene—Diarrhoea—Mitoxantrone—sarcoma	0.000475	0.00226	CcSEcCtD
Raloxifene—Nausea—Dactinomycin—sarcoma	0.000473	0.00226	CcSEcCtD
Raloxifene—Pneumonia—Doxorubicin—sarcoma	0.000472	0.00225	CcSEcCtD
Raloxifene—Gastrointestinal pain—Etoposide—sarcoma	0.000472	0.00225	CcSEcCtD
Raloxifene—Dizziness—Vincristine—sarcoma	0.000471	0.00224	CcSEcCtD
Raloxifene—Rhinitis—Epirubicin—sarcoma	0.000456	0.00217	CcSEcCtD
Raloxifene—Abdominal pain—Etoposide—sarcoma	0.000456	0.00217	CcSEcCtD
Raloxifene—Body temperature increased—Etoposide—sarcoma	0.000456	0.00217	CcSEcCtD
Raloxifene—Conjunctivitis—Doxorubicin—sarcoma	0.000456	0.00217	CcSEcCtD
Raloxifene—Urinary tract infection—Doxorubicin—sarcoma	0.000456	0.00217	CcSEcCtD
Raloxifene—Hypoaesthesia—Epirubicin—sarcoma	0.000453	0.00216	CcSEcCtD
Raloxifene—Vomiting—Vincristine—sarcoma	0.000453	0.00216	CcSEcCtD
Raloxifene—Pharyngitis—Epirubicin—sarcoma	0.000452	0.00215	CcSEcCtD
Raloxifene—Sweating—Doxorubicin—sarcoma	0.00045	0.00214	CcSEcCtD
Raloxifene—Urinary tract disorder—Epirubicin—sarcoma	0.00045	0.00214	CcSEcCtD
Raloxifene—Rash—Vincristine—sarcoma	0.000449	0.00214	CcSEcCtD
Raloxifene—Dermatitis—Vincristine—sarcoma	0.000449	0.00214	CcSEcCtD
Raloxifene—Oedema peripheral—Epirubicin—sarcoma	0.000448	0.00214	CcSEcCtD
Raloxifene—Connective tissue disorder—Epirubicin—sarcoma	0.000447	0.00213	CcSEcCtD
Raloxifene—Urethral disorder—Epirubicin—sarcoma	0.000446	0.00213	CcSEcCtD
Raloxifene—Headache—Vincristine—sarcoma	0.000446	0.00213	CcSEcCtD
Raloxifene—Vomiting—Mitoxantrone—sarcoma	0.000441	0.0021	CcSEcCtD
Raloxifene—Sinusitis—Doxorubicin—sarcoma	0.00044	0.0021	CcSEcCtD
Raloxifene—Rash—Mitoxantrone—sarcoma	0.000437	0.00208	CcSEcCtD
Raloxifene—Dermatitis—Mitoxantrone—sarcoma	0.000437	0.00208	CcSEcCtD
Raloxifene—Headache—Mitoxantrone—sarcoma	0.000435	0.00207	CcSEcCtD
Raloxifene—CYP3A4—liver—sarcoma	0.000431	0.00434	CbGeAlD
Raloxifene—Nausea—Vincristine—sarcoma	0.000423	0.00202	CcSEcCtD
Raloxifene—Cardiac disorder—Epirubicin—sarcoma	0.000422	0.00201	CcSEcCtD
Raloxifene—Flushing—Epirubicin—sarcoma	0.000422	0.00201	CcSEcCtD
Raloxifene—Rhinitis—Doxorubicin—sarcoma	0.000422	0.00201	CcSEcCtD
Raloxifene—Hypoaesthesia—Doxorubicin—sarcoma	0.000419	0.002	CcSEcCtD
Raloxifene—Pharyngitis—Doxorubicin—sarcoma	0.000418	0.00199	CcSEcCtD
Raloxifene—Urinary tract disorder—Doxorubicin—sarcoma	0.000416	0.00198	CcSEcCtD
Raloxifene—Oedema peripheral—Doxorubicin—sarcoma	0.000415	0.00198	CcSEcCtD
Raloxifene—Connective tissue disorder—Doxorubicin—sarcoma	0.000414	0.00197	CcSEcCtD
Raloxifene—Angiopathy—Epirubicin—sarcoma	0.000413	0.00197	CcSEcCtD
Raloxifene—Urethral disorder—Doxorubicin—sarcoma	0.000413	0.00197	CcSEcCtD
Raloxifene—Nausea—Mitoxantrone—sarcoma	0.000412	0.00196	CcSEcCtD
Raloxifene—Diarrhoea—Etoposide—sarcoma	0.000395	0.00188	CcSEcCtD
Raloxifene—ESR1—FOXA1 transcription factor network—JUN—sarcoma	0.000394	0.00297	CbGpPWpGaD
Raloxifene—Flushing—Doxorubicin—sarcoma	0.000391	0.00186	CcSEcCtD
Raloxifene—Cardiac disorder—Doxorubicin—sarcoma	0.000391	0.00186	CcSEcCtD
Raloxifene—Flatulence—Epirubicin—sarcoma	0.00039	0.00186	CcSEcCtD
Raloxifene—Angiopathy—Doxorubicin—sarcoma	0.000382	0.00182	CcSEcCtD
Raloxifene—Dizziness—Etoposide—sarcoma	0.000382	0.00182	CcSEcCtD
Raloxifene—Muscle spasms—Epirubicin—sarcoma	0.000381	0.00182	CcSEcCtD
Raloxifene—ESR1—AP-1 transcription factor network—CREB1—sarcoma	0.000378	0.00285	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000377	0.00284	CbGpPWpGaD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000374	0.00282	CbGpPWpGaD
Raloxifene—Vomiting—Etoposide—sarcoma	0.000367	0.00175	CcSEcCtD
Raloxifene—Rash—Etoposide—sarcoma	0.000364	0.00173	CcSEcCtD
Raloxifene—Dermatitis—Etoposide—sarcoma	0.000363	0.00173	CcSEcCtD
Raloxifene—Headache—Etoposide—sarcoma	0.000361	0.00172	CcSEcCtD
Raloxifene—Flatulence—Doxorubicin—sarcoma	0.000361	0.00172	CcSEcCtD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.00036	0.00271	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—CREB1—sarcoma	0.000358	0.0027	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—FUS—sarcoma	0.000357	0.00269	CbGpPWpGaD
Raloxifene—Vertigo—Epirubicin—sarcoma	0.000356	0.0017	CcSEcCtD
Raloxifene—Syncope—Epirubicin—sarcoma	0.000355	0.00169	CcSEcCtD
Raloxifene—Muscle spasms—Doxorubicin—sarcoma	0.000352	0.00168	CcSEcCtD
Raloxifene—Loss of consciousness—Epirubicin—sarcoma	0.000348	0.00166	CcSEcCtD
Raloxifene—Cough—Epirubicin—sarcoma	0.000346	0.00165	CcSEcCtD
Raloxifene—Nausea—Etoposide—sarcoma	0.000343	0.00163	CcSEcCtD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000341	0.00257	CbGpPWpGaD
Raloxifene—Arthralgia—Epirubicin—sarcoma	0.000337	0.00161	CcSEcCtD
Raloxifene—Chest pain—Epirubicin—sarcoma	0.000337	0.00161	CcSEcCtD
Raloxifene—Myalgia—Epirubicin—sarcoma	0.000337	0.00161	CcSEcCtD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000336	0.00254	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000336	0.00253	CbGpPWpGaD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000335	0.0016	CcSEcCtD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000332	0.00251	CbGpPWpGaD
Raloxifene—Vertigo—Doxorubicin—sarcoma	0.000329	0.00157	CcSEcCtD
Raloxifene—ESR1—FOXM1 transcription factor network—MYC—sarcoma	0.000329	0.00248	CbGpPWpGaD
Raloxifene—Syncope—Doxorubicin—sarcoma	0.000329	0.00157	CcSEcCtD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000328	0.00247	CbGpPWpGaD
Raloxifene—HTR6—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000327	0.00246	CbGpPWpGaD
Raloxifene—ESR1—LKB1 signaling events—MYC—sarcoma	0.000323	0.00243	CbGpPWpGaD
Raloxifene—Loss of consciousness—Doxorubicin—sarcoma	0.000322	0.00154	CcSEcCtD
Raloxifene—Infection—Epirubicin—sarcoma	0.000321	0.00153	CcSEcCtD
Raloxifene—Cough—Doxorubicin—sarcoma	0.00032	0.00152	CcSEcCtD
Raloxifene—Shock—Epirubicin—sarcoma	0.000318	0.00152	CcSEcCtD
Raloxifene—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000318	0.0024	CbGpPWpGaD
Raloxifene—Nervous system disorder—Epirubicin—sarcoma	0.000317	0.00151	CcSEcCtD
Raloxifene—Thrombocytopenia—Epirubicin—sarcoma	0.000317	0.00151	CcSEcCtD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000315	0.00237	CbGpPWpGaD
Raloxifene—Skin disorder—Epirubicin—sarcoma	0.000314	0.0015	CcSEcCtD
Raloxifene—Hyperhidrosis—Epirubicin—sarcoma	0.000313	0.00149	CcSEcCtD
Raloxifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000313	0.00236	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—CCND1—sarcoma	0.000312	0.00235	CbGpPWpGaD
Raloxifene—Myalgia—Doxorubicin—sarcoma	0.000312	0.00149	CcSEcCtD
Raloxifene—Chest pain—Doxorubicin—sarcoma	0.000312	0.00149	CcSEcCtD
Raloxifene—Arthralgia—Doxorubicin—sarcoma	0.000312	0.00149	CcSEcCtD
Raloxifene—ESR1—ATF-2 transcription factor network—JUN—sarcoma	0.000312	0.00235	CbGpPWpGaD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00031	0.00148	CcSEcCtD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.00031	0.00233	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000306	0.0023	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000299	0.00225	CbGpPWpGaD
Raloxifene—HTR2B—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000298	0.00225	CbGpPWpGaD
Raloxifene—Infection—Doxorubicin—sarcoma	0.000297	0.00142	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000295	0.0014	CcSEcCtD
Raloxifene—Shock—Doxorubicin—sarcoma	0.000294	0.0014	CcSEcCtD
Raloxifene—Nervous system disorder—Doxorubicin—sarcoma	0.000293	0.0014	CcSEcCtD
Raloxifene—Thrombocytopenia—Doxorubicin—sarcoma	0.000293	0.0014	CcSEcCtD
Raloxifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000293	0.00221	CbGpPWpGaD
Raloxifene—Insomnia—Epirubicin—sarcoma	0.000292	0.00139	CcSEcCtD
Raloxifene—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000292	0.0022	CbGpPWpGaD
Raloxifene—Skin disorder—Doxorubicin—sarcoma	0.000291	0.00138	CcSEcCtD
Raloxifene—Hyperhidrosis—Doxorubicin—sarcoma	0.000289	0.00138	CcSEcCtD
Raloxifene—ESR1—Regulation of Telomerase—IL2—sarcoma	0.000286	0.00216	CbGpPWpGaD
Raloxifene—Dyspepsia—Epirubicin—sarcoma	0.000285	0.00136	CcSEcCtD
Raloxifene—ESR2—SIDS Susceptibility Pathways—JUN—sarcoma	0.000284	0.00214	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000283	0.00213	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000282	0.00212	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000282	0.00212	CbGpPWpGaD
Raloxifene—EBP—Metabolism—ENO2—sarcoma	0.000281	0.00212	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—FOXO1—sarcoma	0.00028	0.00211	CbGpPWpGaD
Raloxifene—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00028	0.00211	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	0.00028	0.00211	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—IL2—sarcoma	0.00028	0.00211	CbGpPWpGaD
Raloxifene—EBP—Metabolism—HBA1—sarcoma	0.000279	0.00211	CbGpPWpGaD
Raloxifene—Gastrointestinal disorder—Epirubicin—sarcoma	0.000279	0.00133	CcSEcCtD
Raloxifene—ESR1—Regulation of Telomerase—CCND1—sarcoma	0.000279	0.0021	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—JUN—sarcoma	0.000278	0.0021	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000278	0.00209	CbGpPWpGaD
Raloxifene—Pain—Epirubicin—sarcoma	0.000277	0.00132	CcSEcCtD
Raloxifene—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	0.000276	0.00208	CbGpPWpGaD
Raloxifene—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000273	0.0013	CcSEcCtD
Raloxifene—ESR1—AP-1 transcription factor network—CCND1—sarcoma	0.000273	0.00205	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—JUN—sarcoma	0.000272	0.00205	CbGpPWpGaD
Raloxifene—Insomnia—Doxorubicin—sarcoma	0.000271	0.00129	CcSEcCtD
Raloxifene—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	0.00027	0.00203	CbGpPWpGaD
Raloxifene—ESR1—LKB1 signaling events—TP53—sarcoma	0.000265	0.002	CbGpPWpGaD
Raloxifene—Gastrointestinal pain—Epirubicin—sarcoma	0.000264	0.00126	CcSEcCtD
Raloxifene—Dyspepsia—Doxorubicin—sarcoma	0.000263	0.00125	CcSEcCtD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000263	0.00198	CbGpPWpGaD
Raloxifene—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000258	0.00123	CcSEcCtD
Raloxifene—ESR1—Leptin signaling pathway—CCND1—sarcoma	0.000258	0.00194	CbGpPWpGaD
Raloxifene—Pain—Doxorubicin—sarcoma	0.000256	0.00122	CcSEcCtD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000256	0.00193	CbGpPWpGaD
Raloxifene—Body temperature increased—Epirubicin—sarcoma	0.000256	0.00122	CcSEcCtD
Raloxifene—Abdominal pain—Epirubicin—sarcoma	0.000256	0.00122	CcSEcCtD
Raloxifene—ESR2—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000248	0.00187	CbGpPWpGaD
Raloxifene—Gastrointestinal pain—Doxorubicin—sarcoma	0.000245	0.00117	CcSEcCtD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000242	0.00182	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000242	0.00182	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000242	0.00182	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.00024	0.00181	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.00024	0.00181	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PLCG1—sarcoma	0.000239	0.0018	CbGpPWpGaD
Raloxifene—AOX1—Disease—TLE1—sarcoma	0.000238	0.00179	CbGpPWpGaD
Raloxifene—Body temperature increased—Doxorubicin—sarcoma	0.000237	0.00113	CcSEcCtD
Raloxifene—Abdominal pain—Doxorubicin—sarcoma	0.000237	0.00113	CcSEcCtD
Raloxifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000235	0.00177	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—SRC—sarcoma	0.000231	0.00174	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.00023	0.00173	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000228	0.00172	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—MYC—sarcoma	0.000224	0.00169	CbGpPWpGaD
Raloxifene—Diarrhoea—Epirubicin—sarcoma	0.000221	0.00105	CcSEcCtD
Raloxifene—ESR1—Regulation of Telomerase—EGFR—sarcoma	0.000219	0.00165	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—MYC—sarcoma	0.000219	0.00165	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000217	0.00163	CbGpPWpGaD
Raloxifene—AOX1—Disease—NPM1—sarcoma	0.000215	0.00162	CbGpPWpGaD
Raloxifene—Dizziness—Epirubicin—sarcoma	0.000214	0.00102	CcSEcCtD
Raloxifene—ESR1—Signaling by ERBB4—KIT—sarcoma	0.000214	0.00161	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—CXCR4—sarcoma	0.000213	0.00161	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000211	0.00159	CbGpPWpGaD
Raloxifene—Vomiting—Epirubicin—sarcoma	0.000206	0.00098	CcSEcCtD
Raloxifene—Diarrhoea—Doxorubicin—sarcoma	0.000205	0.000975	CcSEcCtD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000204	0.00154	CbGpPWpGaD
Raloxifene—Rash—Epirubicin—sarcoma	0.000204	0.000971	CcSEcCtD
Raloxifene—Dermatitis—Epirubicin—sarcoma	0.000204	0.000971	CcSEcCtD
Raloxifene—ESR1—Signaling by ERBB4—CREB1—sarcoma	0.000203	0.00153	CbGpPWpGaD
Raloxifene—Headache—Epirubicin—sarcoma	0.000203	0.000965	CcSEcCtD
Raloxifene—Dizziness—Doxorubicin—sarcoma	0.000198	0.000943	CcSEcCtD
Raloxifene—HTR2B—GPCR ligand binding—CXCR4—sarcoma	0.000195	0.00147	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000194	0.00147	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000194	0.00146	CbGpPWpGaD
Raloxifene—Nausea—Epirubicin—sarcoma	0.000192	0.000915	CcSEcCtD
Raloxifene—Vomiting—Doxorubicin—sarcoma	0.00019	0.000906	CcSEcCtD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.00019	0.00143	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000189	0.00142	CbGpPWpGaD
Raloxifene—Rash—Doxorubicin—sarcoma	0.000189	0.000899	CcSEcCtD
Raloxifene—Dermatitis—Doxorubicin—sarcoma	0.000188	0.000898	CcSEcCtD
Raloxifene—Headache—Doxorubicin—sarcoma	0.000187	0.000893	CcSEcCtD
Raloxifene—AOX1—Disease—ENO2—sarcoma	0.000186	0.0014	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	0.000185	0.00139	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—FUS—sarcoma	0.00018	0.00136	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TP53—sarcoma	0.00018	0.00135	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000179	0.00135	CbGpPWpGaD
Raloxifene—Nausea—Doxorubicin—sarcoma	0.000178	0.000847	CcSEcCtD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000169	0.00128	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000169	0.00127	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—MDM2—sarcoma	0.000168	0.00127	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000165	0.00124	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000164	0.00124	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000163	0.00123	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—HRAS—sarcoma	0.000162	0.00122	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000159	0.0012	CbGpPWpGaD
Raloxifene—AOX1—Disease—PLCG1—sarcoma	0.000158	0.00119	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ENO2—sarcoma	0.000156	0.00117	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—HBA1—sarcoma	0.000155	0.00117	CbGpPWpGaD
Raloxifene—AOX1—Disease—CXCR4—sarcoma	0.000152	0.00114	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000147	0.00111	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000147	0.00111	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000146	0.0011	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000143	0.00108	CbGpPWpGaD
Raloxifene—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000143	0.00108	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.00014	0.00106	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PLCG1—sarcoma	0.000132	0.000996	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000132	0.000995	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000129	0.000973	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000128	0.000968	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—NRAS—sarcoma	0.000126	0.000951	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000122	0.00092	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000122	0.000919	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000122	0.000918	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000121	0.000911	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CXCR4—sarcoma	0.000121	0.000909	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000118	0.000891	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000116	0.000871	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—EGFR—sarcoma	0.000115	0.000866	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	0.000115	0.000865	CbGpPWpGaD
Raloxifene—AOX1—Disease—FOXO1—sarcoma	0.000112	0.000844	CbGpPWpGaD
Raloxifene—AOX1—Disease—PDGFRB—sarcoma	0.000112	0.000843	CbGpPWpGaD
Raloxifene—AOX1—Disease—PDGFRA—sarcoma	0.00011	0.00083	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CXCR4—sarcoma	0.00011	0.000829	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CXCR4—sarcoma	0.000109	0.000825	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000109	0.000823	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000109	0.000823	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—KRAS—sarcoma	0.000109	0.000819	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000108	0.000817	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000106	0.000802	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.000105	0.000788	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TLE1—sarcoma	0.000102	0.000765	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CXCR4—sarcoma	9.99e-05	0.000753	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	9.88e-05	0.000745	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	9.79e-05	0.000738	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	9.7e-05	0.000731	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—MYC—sarcoma	9.65e-05	0.000727	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	9.58e-05	0.000722	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TLE1—sarcoma	9.27e-05	0.000698	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—HRAS—sarcoma	9.23e-05	0.000696	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	9.05e-05	0.000682	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFC—sarcoma	8.57e-05	0.000646	CbGpPWpGaD
Raloxifene—AOX1—Disease—KIT—sarcoma	8.54e-05	0.000643	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	8.4e-05	0.000633	CbGpPWpGaD
Raloxifene—AOX1—Disease—CREB1—sarcoma	8.12e-05	0.000612	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ENO2—sarcoma	8.06e-05	0.000607	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.04e-05	0.000606	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—HBA1—sarcoma	8.01e-05	0.000603	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFC—sarcoma	7.82e-05	0.000589	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TLE1—sarcoma	7.72e-05	0.000582	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FLT1—sarcoma	6.85e-05	0.000516	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PLCG1—sarcoma	6.84e-05	0.000515	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PLCG1—sarcoma	6.73e-05	0.000507	CbGpPWpGaD
Raloxifene—AOX1—Disease—MDM2—sarcoma	6.72e-05	0.000507	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFC—sarcoma	6.51e-05	0.000491	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CXCR4—sarcoma	6.47e-05	0.000487	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ATF1—sarcoma	6.39e-05	0.000482	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FLT1—sarcoma	6.25e-05	0.000471	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PLCG1—sarcoma	6.14e-05	0.000463	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CXCR4—sarcoma	5.9e-05	0.000445	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CREB1—sarcoma	5.86e-05	0.000442	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ATF1—sarcoma	5.84e-05	0.00044	CbGpPWpGaD
Raloxifene—AOX1—Disease—CTNNB1—sarcoma	5.8e-05	0.000437	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CREB1—sarcoma	5.35e-05	0.000403	CbGpPWpGaD
Raloxifene—AOX1—Disease—SRC—sarcoma	5.24e-05	0.000395	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FLT1—sarcoma	5.21e-05	0.000392	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ENO2—sarcoma	5.18e-05	0.00039	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HBA1—sarcoma	5.14e-05	0.000388	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PLCG1—sarcoma	5.12e-05	0.000386	CbGpPWpGaD
Raloxifene—AOX1—Disease—NRAS—sarcoma	5.04e-05	0.00038	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF1R—sarcoma	5.02e-05	0.000378	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CXCR4—sarcoma	4.92e-05	0.000371	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MYC—sarcoma	4.86e-05	0.000367	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ATF1—sarcoma	4.86e-05	0.000366	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FOXO1—sarcoma	4.78e-05	0.00036	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—IL2—sarcoma	4.77e-05	0.00036	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PDGFRB—sarcoma	4.77e-05	0.000359	CbGpPWpGaD
Raloxifene—AOX1—Disease—MYC—sarcoma	4.7e-05	0.000354	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PDGFRA—sarcoma	4.69e-05	0.000354	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MYC—sarcoma	4.64e-05	0.00035	CbGpPWpGaD
Raloxifene—AOX1—Disease—EGFR—sarcoma	4.59e-05	0.000346	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF1R—sarcoma	4.58e-05	0.000345	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PLCG1—sarcoma	4.39e-05	0.000331	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ENO2—sarcoma	4.38e-05	0.00033	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FOXO1—sarcoma	4.36e-05	0.000329	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—IL2—sarcoma	4.36e-05	0.000328	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HBA1—sarcoma	4.35e-05	0.000328	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PDGFRB—sarcoma	4.35e-05	0.000328	CbGpPWpGaD
Raloxifene—AOX1—Disease—KRAS—sarcoma	4.34e-05	0.000327	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL2—sarcoma	4.34e-05	0.000327	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PDGFRA—sarcoma	4.28e-05	0.000323	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL2—sarcoma	3.96e-05	0.000298	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KDR—sarcoma	3.95e-05	0.000298	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1R—sarcoma	3.82e-05	0.000288	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PLCG1—sarcoma	3.72e-05	0.00028	CbGpPWpGaD
Raloxifene—AOX1—Disease—HRAS—sarcoma	3.69e-05	0.000278	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KIT—sarcoma	3.64e-05	0.000274	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—NRAS—sarcoma	3.64e-05	0.000274	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FOXO1—sarcoma	3.63e-05	0.000274	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PDGFRB—sarcoma	3.63e-05	0.000273	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KDR—sarcoma	3.61e-05	0.000272	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PDGFRA—sarcoma	3.57e-05	0.000269	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CREB1—sarcoma	3.46e-05	0.000261	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KIT—sarcoma	3.32e-05	0.00025	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—NRAS—sarcoma	3.32e-05	0.00025	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EGFR—sarcoma	3.32e-05	0.00025	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CREB1—sarcoma	3.16e-05	0.000238	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—KRAS—sarcoma	3.13e-05	0.000236	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EGFR—sarcoma	3.03e-05	0.000228	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KDR—sarcoma	3e-05	0.000226	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MDM2—sarcoma	2.87e-05	0.000216	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—KRAS—sarcoma	2.86e-05	0.000215	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KIT—sarcoma	2.77e-05	0.000209	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HRAS—sarcoma	2.66e-05	0.000201	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CREB1—sarcoma	2.63e-05	0.000199	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MDM2—sarcoma	2.62e-05	0.000197	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL2—sarcoma	2.56e-05	0.000193	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCND1—sarcoma	2.5e-05	0.000188	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—JUN—sarcoma	2.49e-05	0.000188	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CTNNB1—sarcoma	2.47e-05	0.000186	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HRAS—sarcoma	2.43e-05	0.000183	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ENO2—sarcoma	2.35e-05	0.000177	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MYC—sarcoma	2.34e-05	0.000176	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL2—sarcoma	2.34e-05	0.000176	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HBA1—sarcoma	2.34e-05	0.000176	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCND1—sarcoma	2.28e-05	0.000172	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—JUN—sarcoma	2.27e-05	0.000171	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CTNNB1—sarcoma	2.26e-05	0.00017	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SRC—sarcoma	2.23e-05	0.000168	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MDM2—sarcoma	2.18e-05	0.000164	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—sarcoma	2.18e-05	0.000164	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NRAS—sarcoma	2.15e-05	0.000162	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SRC—sarcoma	2.04e-05	0.000154	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MYC—sarcoma	2e-05	0.000151	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLCG1—sarcoma	2e-05	0.00015	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—sarcoma	1.99e-05	0.00015	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NRAS—sarcoma	1.96e-05	0.000148	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EGFR—sarcoma	1.96e-05	0.000148	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL2—sarcoma	1.95e-05	0.000147	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCND1—sarcoma	1.9e-05	0.000143	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—JUN—sarcoma	1.89e-05	0.000143	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CTNNB1—sarcoma	1.88e-05	0.000142	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KRAS—sarcoma	1.85e-05	0.000139	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MYC—sarcoma	1.83e-05	0.000138	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EGFR—sarcoma	1.79e-05	0.000135	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SRC—sarcoma	1.7e-05	0.000128	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KRAS—sarcoma	1.69e-05	0.000127	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—sarcoma	1.65e-05	0.000125	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—sarcoma	1.64e-05	0.000124	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NRAS—sarcoma	1.63e-05	0.000123	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HRAS—sarcoma	1.57e-05	0.000119	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MYC—sarcoma	1.52e-05	0.000115	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—sarcoma	1.5e-05	0.000113	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EGFR—sarcoma	1.49e-05	0.000112	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HRAS—sarcoma	1.44e-05	0.000108	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KRAS—sarcoma	1.41e-05	0.000106	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—sarcoma	1.25e-05	9.42e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HRAS—sarcoma	1.2e-05	9.01e-05	CbGpPWpGaD
